Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care AG & Co. KGaA (DE:FME)
XETRA:FME
FME Stock Chart & Stats
€40.45
-€0.05(-0.11%)
At close: 4:00 PM EST
€40.45
-€0.05(-0.11%)
Day’s Range― - ―
52-Week Range€39.43 - €54.02
Previous CloseN/A
Volume12.09K
Average Volume (3M)529.60K
Market Cap
€11.96B
Enterprise Value€24.64B
Total Cash (Recent Filing)€2.19B
Total Debt (Recent Filing)€11.02B
Price to Earnings (P/E)18.4
Beta0.74
Next Earnings
Feb 24, 2026Last Dividend Ex-Date
May 23, 2025Dividend Yield3.56%
Share Statistics
EPS (TTM)1.10
Shares Outstanding293,413,450
10 Day Avg. Volume492,004
30 Day Avg. Volume529,597
Financial Highlights & Ratios
PEG Ratio3.15
Price to Book (P/B)0.89
Price to Sales (P/S)0.67
P/FCF Ratio7.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€45.00Price Target Upside11.25% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering11
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial PerformanceFresenius continues to execute on FME25 savings, with €128mn achieved in the first half against a total annual target of €180mn.
Stock BuybackThe first tranche of the buyback is planned to begin, and the HV HDF rollout is positioned to begin soon, which are positive updates.
Technology RolloutThe rollout of HV HDF technology is underway, offering benefits like a reduction in mortality of 18 months after 2-3 years of treatment.
Bears Say
Growth ChallengesThe US SMTG, a key growth and sentiment driver, has struggled to meet growth targets and is expected to remain flat.
Market ValuationThe company's growth and margins are lagging behind the sector, leading to a 46% discount in trading valuation.
Revenue PressureMargins are expected to come under pressure from a rising share of margin-dilutive revenue and potential roll-off of subsidies.
Fresenius Medical Care AG & Co. KGaA News
FME FAQ
What was Fresenius Medical Care AG & Co. KGaA’s price range in the past 12 months?
Fresenius Medical Care AG & Co. KGaA lowest stock price was €39.43 and its highest was €54.02 in the past 12 months.
What is Fresenius Medical Care AG & Co. KGaA’s market cap?
Fresenius Medical Care AG & Co. KGaA’s market cap is €11.96B.
When is Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date?
Fresenius Medical Care AG & Co. KGaA’s upcoming earnings report date is Feb 24, 2026 which is in 98 days.
How were Fresenius Medical Care AG & Co. KGaA’s earnings last quarter?
Fresenius Medical Care AG & Co. KGaA released its earnings results on Nov 04, 2025. The company reported €1.1 earnings per share for the quarter, beating the consensus estimate of €1.042 by €0.058.
Is Fresenius Medical Care AG & Co. KGaA overvalued?
According to Wall Street analysts Fresenius Medical Care AG & Co. KGaA’s price is currently Undervalued.
Does Fresenius Medical Care AG & Co. KGaA pay dividends?
Fresenius Medical Care AG & Co. KGaA pays a Annually dividend of €1.44 which represents an annual dividend yield of 3.56%. See more information on Fresenius Medical Care AG & Co. KGaA dividends here
What is Fresenius Medical Care AG & Co. KGaA’s EPS estimate?
Fresenius Medical Care AG & Co. KGaA’s EPS estimate is 1.
How many shares outstanding does Fresenius Medical Care AG & Co. KGaA have?
Fresenius Medical Care AG & Co. KGaA has 293,413,450 shares outstanding.
What happened to Fresenius Medical Care AG & Co. KGaA’s price movement after its last earnings report?
Fresenius Medical Care AG & Co. KGaA reported an EPS of €1.1 in its last earnings report, beating expectations of €1.042. Following the earnings report the stock price went down -9.853%.
Which hedge fund is a major shareholder of Fresenius Medical Care AG & Co. KGaA?
Currently, no hedge funds are holding shares in DE:FME
Fresenius Medical Care AG & Co. KGaA Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
€45.00 (11.25% Upside)
€45.00 (11.25% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.79%
12-Months-Change
Fundamentals
Return on Equity
5.41%
Trailing 12-Months
Asset Growth
-7.69%
Trailing 12-Months
Company Description
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA (FME) is a global healthcare company based in Germany, specializing in products and services for individuals with renal diseases. With a strong focus on dialysis, the company operates in two primary segments: the production of dialysis products, including machines and consumables, and the provision of dialysis treatment services through its extensive network of outpatient clinics and in-center facilities. Fresenius Medical Care is a leader in the renal care market, aiming to improve the quality of life for patients with chronic kidney failure.
FME Stock 12 Month Forecast
Average Price Target
€45.00
▲(11.25% Upside)
Technical Analysis
Options Prices
Currently, No data available
---